ResoTher Pharma
- Biotech or pharma, therapeutic R&D
ResoTher Pharma is developing a novel class of peptide therapeutics that rapidly cause resolution of inflammation via agonism of FPR2.
June 16-19, 2025
Boston Convention & Exhibition Center